通过联合抗肥胖药物治疗方案减肥可以接近通过腹部手术实现的减肥
Priya N Patel1, Claudia K Fox1, Megan O Bensignor1,2
1Center for Pediatric Obesity Medicine, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.
JCEM case reports
|November 1, 2023
概括
组合抗肥药物,包括类似葡萄糖素的-1受体激动剂,对于显著的减肥可以非常有效. 这种方法可能为严重肥胖的个体提供协同效益,这些个体对单一治疗没有充分的反应.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
- 肥胖医学 肥胖医学
背景情况:
- 肥胖是一种复杂的慢性疾病,具有具有挑战性的治疗结果.
- 改变生活方式是主要的治疗方法,但抗肥胖药物可以促进减肥.
- 当单一疗法产生低于最佳结果时,组合疗法可能是有效的.
研究的目的:
- 报告一个证明联合抗肥胖药物疗法的疗效的病例.
- 突出葡萄糖类-1受体激动剂在治疗严重肥胖症中的作用.
- 探索针对肥胖症治疗中的多个途径的协同效应.
主要方法:
- 一个23岁的男性严重肥胖 (BMI 84.3 kg/m2) 的案例研究.
- 最初的治疗包括改变生活方式,服用胺,托皮拉和甲胺.
- 随后添加了semaglutide (一种类似葡萄糖素的-1受体激动剂) 和低热量饮食.
主要成果:
- 单疗法导致体重稳定在一年后.
- 添加西马格卢提德导致总体体重减少了32.5%.
- 这种体重减轻与代谢/腹腔外科手术实现的体重减轻相当.
结论:
- 组合抗肥药物治疗方案,特别是包括葡萄糖类-1受体激动剂的组合药物治疗方案,显示出显著的潜力.
- 这种饮食方案可能通过同时解决多个饮食行为路径来提供协同效应.
- 进一步的研究是有必要的,以评估组合疗法在患者与单一治疗的最佳反应.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Insulin: Dosing Regimen and Adverse Effects
184
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
184
Oral Hypoglycemic Agents: Biguanides and Glitazones
212
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
212
Obesity
509
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
509
Drugs for Treatment of Constipation-Predominant IBS
181
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
181
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K


